Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesEfficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial : The Lancet
The Lancet - Early Online Publication, 10/09/09
Sur D et al. – This modified killed–whole–cell oral vaccine, compliant with WHO standards, is safe, provides protection against clinically significant cholera in an endemic setting, and can be used in children aged 1·0—4·9 years, who are at highest risk of developing cholera in endemic settings.
Related Articles
Epidemics of severe cholera caused by El Tor Vibrio cholerae O1 Ogawa possessing the ctxB gene of the classical biotype in Orissa, India
International Journal of Infectious Diseases, 10/01/09
Relevance Score: 91%
Clinical Outcomes in Household Contacts of Patients with Cholera in Bangladesh
Clinical Infectious Diseases, 10/28/09
Relevance Score: 90%
A multiplatform real-time polymerase chain reaction detection assay for Vibrio cholerae
Diagnostic Microbiology and Infectious Disease, 10/22/09
Relevance Score: 90%
Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial
The Lancet, 11/16/09
Relevance Score: 89%
Quorum sensing negatively regulates hemolysin transcriptionally and post-translationally in Vibrio cholerae
Infection and Immunity, 10/30/09
Relevance Score: 87%
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Overview of hypersensitivity to cancer therapies
Community Oncology , 03/19/10
Radioimmunotherapy: a promising treatment strategy for follicular lymphoma
Community Oncology , 03/19/10
Immunogenicity and protective efficacy of mycobacterial DNA vaccines incorporating plasmid-encoded cytokines against Mycobacterium bovis
Immunology & Cell Biology, 03/19/10
Article Search
Sponsor
Sponsor